The endodomain of several coronavirus (CoV) spike (S) proteins contains palmitylated cysteine residues and enables co-localization and interaction with the CoV membrane (M) protein.
Severe acute respiratory syndrome (SARS) is a life-threatening disease caused by the SARS coronavirus (SCoV) (Drosten et al., 2003; Fouchier et al., 2003; Ksiazek et al., 2003) . SCoV belongs to the family Coronaviridae, which contains enveloped viruses with positive-sense ssRNA genomes. The virion of CoV carries four structural proteins: spike (S), membrane (M), small envelope (E) and nucleocapsid (N) (Rota et al., 2003) ; some CoVs contain an additional membrane protein, haemagglutinin-esterase (HE).
CoVs assemble intracellularly, bud into the lumen of the endoplasmic reticulum (ER) Golgi intermediate compartment (ERGIC), and then are released from cells by exocytosis (Klumperman et al., 1994) . For efficient virus assembly, the structural proteins target and accumulate in the ERGIC. The M and E proteins of many CoVs harbour Golgi-targeting signals that localize them near the assembly site (Corse & Machamer, 2000 . Some CoV S proteins contain ER-retrieval signals, whereas others do not (Lontok et al., 2004; McBride et al., 2007; Schwegmann-Wessels et al., 2004; Shirato et al., 2010 Shirato et al., , 2011 Winter et al., 2008) . However, previous studies have shown that even SCoV S proteins with weak ER-retrieval signals localize predominantly to the cell surface (McBride et al., 2007) . It is only when they are co-expressed with SCoV M protein that S proteins can be retained intracellularly and colocalize with M proteins. The N and HE proteins, which do not have such signals, also localize to the assembly site by interacting with the M protein. As M is necessary for viruslike particle (VLP) formation (Corse & Machamer, 2000; Huang et al., 2004; Siu et al., 2008) and interaction with other structural proteins can mediate its incorporation into virions and VLPs (de Haan et al., 1999; Haijema et al., 2003; Kuo & Masters, 2002; McBride & Machamer, 2010b; Narayanan & Makino, 2001; Nguyen & Hogue, 1997; Opstelten et al., 1995; Vennema et al., 1996) , M is a key player in virion assembly (McBride et al., 2007; Nguyen & Hogue, 1997; Opstelten et al., 1995) .
The CoV S protein is a class I fusion protein, and protease treatment of S generates the S1 and S2 subunits (Kawase et al., 2009; Matsuyama et al., 2005; Ujike et al., 2008) . The S1 subunit contains a binding domain for a host-cell receptor (Dveksler et al., 1993; Li et al., 2005) , while the S2 subunit is responsible for virus entry and cell fusion. The CoV S2 subunit is composed of a large ectodomain, a transmembrane domain (TMD) and a cytoplasmic tail (CT), although the exact border between the TMD and CT has not yet been identified. A characteristic feature of the TMD and CT is the presence of a remarkably dense cluster of cysteine residues. This cysteine-rich domain of SCoV and mouse hepatitis virus (MHV) can be divided into two cysteine-rich motifs, CRM1 and CRM2 (Fig. 1a ). Some cysteine residues within these motifs are modified with palmitic acid (Bos et al., 1995; Petit et al., 2007) .
Palmitylation of CoV S proteins is important for fusion activity and virus assembly. Past studies of SCoV and MHV S proteins demonstrated that palmitylated cysteine residues in CRM1 are required for cell-cell fusion (Bos et al., 1995; Chang et al., 2000; Petit et al., 2007) . In contrast, underpalmitylation of MHV S proteins, achieved by using a specific inhibitor of palmitylation (2-bromopalmitate) in infected cells or by introducing cysteine-to-alanine substitutions in CRM2, showed reduced ability of M-S interactions and resulted in the failure of S incorporation into the virion (Shulla & Gallagher, 2009; Thorp et al., 2006) . These findings suggest a causal relationship between the M-S interaction and S incorporation and indicate that palmitylated cysteine residues in CRM2 are required for both of these processes.
Recently, McBride & Machamer (2010a) created a nonpalmitylated SCoV S mutant by substituting all of the cysteines with alanine residues. Indirect immunofluorescence microscopy showed that both wild-type (WT) and non-palmitylated SCoV S proteins localized to the cell surface when expressed individually; however, when either protein was co-expressed with the SCoV M protein, each co-localized with M in the budding site. These results implied that palmitylation of SCoV S protein was not necessary for its interaction with SCoV M, which is quite different from studies with the MHV S protein. From this result, they expected that both proteins would be incorporated efficiently into virions. However, whether the WT and non-palmitylated SCoV S proteins are different in their ability to be incorporated into virions was not addressed in that study.
In this study, we generated a comprehensive set of SCoV S mutants that lack cysteine residues and tested their ability to be incorporated into VLPs. Both CRM1 and CRM2 carry two cysteine-rich clusters, designated A and B (Fig.  1a ). cDNAs encoding SCoV S, M, E and N proteins (Frankfurt strain) were subcloned into EcoRI sites within the pCAGGS expression vector. Site-directed mutagenesis was performed using standard PCR protocols with the overlap-extension technique (Horton & Pease, 1991) .
To determine whether the SCoV S mutants were palmitylated, COS-7 cells transiently expressing the various S protein mutants were metabolically labelled with either SDS, 0.1 % bromophenol blue and 10 % glycerol). The resultant solution was subjected to SDS-PAGE and visualized by autoradiography using a FUJIX BAS 2500 system (Fujifilm). As shown in Fig. 1(b) , multimeric forms of SCoV S proteins were predominantly detected under these conditions. All S mutant proteins were labelled with [ 35 S]methionine-cysteine to a similar extent as the WT S protein. The CRM1-and CRM2-mutated S proteins (i.e. mutants 1A, 1B, 2A, 2B, 1 and 2) were labelled with [ 3 H]palmitic acid, whereas mutant 12, which lacked all cysteine residues, was not labelled (Fig. 1b) . Densitometer analysis revealed that mutant 1 reduced the incorporation of palmitic acid by approximately 70 %, consistent with a previous study (Petit et al., 2007) . Our results suggest that cysteine residues of both CRM1 and CRM2 are palmitylation sites.
We next wanted to determine whether depalmitylated SCoV S mutants could be incorporated efficiently into SCoV VLPs (Huang et al., 2006) . To do this, 293T cells in a 60 mm dish were cotransfected with 1.0 mg pCAGGS-SCoV S, 4.7 mg pCAGGS-SCoV E, 0.5 mg pCAGGS-SCoV M and 1.0 mg pCAGGS-SCoV N using TransIT 293 Transfection Reagent (Mirus Bio). At 72 h post-transfection, VLPs released into the culture medium were harvested and pelleted though a 20 % sucrose cushion at 45 000 r.p.m. for 2 h (SW55Ti rotor; Beckman). The production of VLPs and the accumulation of SCoV proteins within the cells were detected by Western blot analysis. S, N and M proteins were detected with the anti-S antibody IMG-557 (Imgenex) or anti-SCoV N or M protein rabbit polyclonal antiserum (generously provided by Dr Mizutani), together with HRPconjugated anti-rabbit IgG (Invitrogen). Protein bands were visualized using ECLplus (GE Healthcare) on an LAS-1000 instrument (Fujifilm).
As shown in Fig. 2(a) , co-expression of SCoV N, M, E and WT S proteins resulted in VLP release. Excluding the S protein plasmid from the transfection mixture resulted in the release of VLPs lacking the S protein. SCoV S mutant proteins with cysteine substitutions at the 2B cluster of CRM2 (i.e. mutants 2B, 2 and 12) were not detected in the released VLPs, in contrast to the other S mutants. As accumulation of intracellular S mutants 2B, 2 or 12 was similar to that of WT S (Fig. 2a) , the lack of incorporation of these mutants into VLPs was not due to poor accumulation. In addition, S proteins were not detected in medium when only the S protein plasmid was transfected into 293T cells, demonstrating that S proteins in medium were not derived from secreted free S proteins (Fig. 2b) . These results demonstrated that two palmitylated cysteine residues of CRM2B (i.e. C 1234 and C 1235 ) are essential for S incorporation into SCoV VLPs.
Previous studies using indirect immunofluorescence microscopy demonstrated that depalmitylated SCoV S proteins co-localize with SCoV M proteins (McBride & Machamer, 2010a) . These results imply the ability of S to interact with M proteins, so its lack of incorporation into VLPs was unexpected. To confirm whether the SCoV S mutants generated in this study could co-localize with SCoV M proteins, their subcellular locations within COS-7 cells were evaluated by indirect immunofluorescence microscopy under permeabilized and non-permeabilized conditions. COS-7 cells were cotransfected with 1.0 mg pCAGGS-SCoV S and 0.5 mg of either pCAGGS-SCoV M or empty pCAGGS vector. At 40 h post-transfection, SCoV S and M protein-expressing COS-7 cells were fixed with 4 % paraformaldehyde for 15 min at room temperature and permeabilized, or not, with 0.1 % Triton X-100 for 20 min at room temperature. The cells were then stained with anti-SCoV S mouse mAb (Ohnishi et al., 2005) and anti-SCoV M rabbit polyclonal antiserum, using Alexa Fluor 594-conjugated goat anti-mouse IgG (Invitrogen) and FITC-conjugated goat anti-rabbit IgG secondary antibodies. Images were obtained with an Axioscope microscope (Carl Zeiss). The representative SCoV S mutant 2B, which failed to be incorporated into VLPs, is shown in Fig. 3 . When mutant 2B was expressed alone, it localized predominantly to the cell surface (Fig. 3a, left) . In contrast, when it was co-expressed with SCoV M, mutant 2B was retained intracellularly (Fig. 3a, right) and colocalized with M (Fig. 3b) . All of the other SCoV S mutants, including non-palmitylated mutant 12, stained similarly (data not shown), consistent with previous studies (McBride & Machamer, 2010a) . Thus, all of the SCoV S mutants generated in this study co-localize efficiently with the SCoV M protein. In summary, we demonstrated that two palmitylated cysteines in CRM2B of the SCoV S protein are essential for S incorporation into VLPs, but not for the S colocalization mediated by the SCoV M protein in the budding site. This is in contrast to studies of the MHV S protein (Shulla & Gallagher, 2009; Thorp et al., 2006) . Palmitylation of MHV S protein was required for MHV M-S co-localization and interaction, which are thought to mediate MHV S incorporation into virions. C-terminal truncation mutants of MHV S, which lacked cysteine residues in CRM2, were unable to interact with MHV M, resulting in no S incorporation (Bosch et al., 2005) . Thus, M-S co-localization/interaction and S incorporation were both dependent on palmitylated cysteines within MHV S proteins. However, our study demonstrated that, in the case of SCoV S proteins, the absence of cysteine residues in CRM2B did not affect M-S co-localization, but failed to allow S incorporation, indicating the independence of these two functions. Importantly, these data also suggest that intracellular retention of S proteins within the virionassembly site, which is mediated by M protein, is not sufficient for S incorporation and requires two palmitylated cysteines within the S protein.
It is unclear why SCoV M-S co-localization occurs independently of SCoV S incorporation. A few possible explanations are conceivable. As the M-S co-localization detected by indirect immunofluorescence assay does not necessarily reflect direct M-S interaction, we could not exclude the possibility that, despite M-S co-localization, depalmitylated SCoV S proteins might not interact directly with SCoV M proteins, resulting in a failure of S incorporation into VLPs. However, this seems unlikely because findings from an in vitro binding assay suggested that the recombinant SCoV S-tail domain purified from a bacterial expression system, which was not palmitylated, was able to interact with SCoV M proteins (McBride et al., 2007) . Given that depalmitylated SCoV S proteins could interact with the SCoV M protein, another possible explanation is as follows. During virion and VLP assembly, it is hypothesized that M proteins interact through multiple contact sites, creating a dense matrix of protein within the viral membrane (de Haan et al., 2000) . This dense matrix, formed by lateral M-M interactions, may limit the space available for membrane-spanning S proteins. Therefore, in addition to M binding, efficient S incorporation also requires that S adapts an appropriate structure to accommodate its endodomain in the limited space. Although we showed in mutant 1 that cysteines in only CRM2 (2A and 2B) were palmitylated, we could not rule out the possibility that cysteine(s) in the 2A rather than the 2B region were palmitylated. Thus, the two hydrophobic palmitic acids branching off CRM2B into the inner membrane, or the non-palmitylated cysteine(s) themselves, may contribute to formation of such a structure. Our data highlight the mechanistic differences of S incorporation between MHV and SCoV. 
